Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
/DISREGARD RELEASE: XRP Healthcare/
PR Newswire
01/07/2024
Adoption of MIS Approaches to Broaden Scope for Global Dental Laser Market to…
Growing educational campaigns to make healthcare professionals aware of the product and their advanced technology. Advancements such as lasers which are employed for repairing tooth porosity, welding implants, fixing broken clasps, and Dental Lasers. For instance, Er:YAG lasers are now used as an alternative to acid etching of enamel. Growing educational campaigns to make healthcare professionals aware of the product and their advanced technology. Advancements such as lasers which are…
PR Newswire
01/07/2024
Photoacoustic Imaging Market: Reaching USD 105 Million by 2029 - Drivers…
Browse in-depth TOC on "Photoacoustic Imaging Market" Browse in-depth TOC on "Photoacoustic Imaging Market" 121 - Tables47 - Figures 171 - Pages Competitive Landscape and Key Players The photoacoustic imaging market is characterized by a competitive landscape with various established and emerging players. Key stakeholders as of 2023 include Advantest Corporation, Cyberdyne, Inc., Fujifilm Corporation, IllumiSonics Inc., iThera Medical Gmbh, Kibero, Opotel LLC, TomoWave...
PR Newswire
01/07/2024
DC Torque Tool Market worth $4.4 billion by 2029 - Exclusive Report by…
Browse in-depth TOC on "DC Torque Tool Market" 200 – Tables71 – Figures227 – Pages Browse in-depth TOC on "DC Torque Tool Market"200 – Tables 71 – Figures 227 – Pages DC Torque Tool Market Report Scope: The handheld tools segment is to grow with a higher CAGR during the forecast period. The DC torque tool have been segmented into two tool types, handheld tools and fixtured tools. Handheld tools are preferred over fixtured tools due to portability, handheld tools can be...
PR Newswire
01/07/2024
Soft Tissue Repair Market Size to Worth USD 12.78 Billion by 2034 | With 5.6%…
Because of the increasing aging population, demand for orthopedic procedures is increasing at a significant pace, offering lucrative prospects for soft tissue repair solution providers. Chronic conditions like diabetes-related gangrene, osteoarthritis, and peripheral vascular disease are boosting the demand for orthopedic procedures, including amputations. Consequently, there is a surge in overall sales within the soft tissue repair market. Because of the increasing aging population, demand…
PR Newswire
01/07/2024
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 01 July 2024– On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the…
Nasdaq GlobeNewswire
01/07/2024
Buyback of Class B shares in Essity during week 26, 2024
The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All...
PR Newswire
01/07/2024
Inside information: Orion and MSD Announce Mutual Exercise of Option Providing…
ORION CORPORATIONSTOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate CancerOrion Corporation (“Orion”) and MSD (Merck & Co., Inc., Rahway, NJ, USA) today announced that notice has been provided of the mutual exercise of an option to...
Nasdaq GlobeNewswire
01/07/2024
Inside information: Orion upgrades full-year outlook for 2024
ORION CORPORATIONSTOCK EXCHANGE RELEASE – INSIDE INFORMATION 1 JULY 2024 at 15:15 EEST Inside information: Orion upgrades full-year outlook for 2024Orion Corporation upgrades the full-year outlook for 2024 both for the part regarding net sales and operating profit. Orion and MSD (Merck & Co., Inc., Rahway, NJ, USA) have exercised the option to convert the co-development and co-commercialisation agreement with MSD regarding opevesostat (MK-5684/ODM-208), an investigational...
Nasdaq GlobeNewswire
01/07/2024
2024 International Pharmaceutical Cooperation High-End Forum Kexing Biopharm's…
During the forum, Kexing Biopharm warmly welcomed and sincerely thanked the attendees from various backgrounds who had traveled from afar. In addition, they provided a comprehensive introduction to the Company's internationalization strategy and plans for the future. Kexing Biopharm emphasized its commitment to leveraging its overseas commercial platform to deliver high-quality products and comprehensive medication solutions for global patients. It specifically mentioned the successful…
PR Newswire
01/07/2024
Ping An Co-CEO Michael Guo at "Summer Davos": Low Public Awareness of Financial…
China is aging before becoming rich, Mr. Guo said. When China entered the phase of an aging society in 1999, the GDP per capita was only US$1,000. In comparison, when developed countries in Europe and the US encountered aging populations, their GDP per capita was approximately US$10,000, so they had stronger financial capacity to support senior care. Today, the challenge in China is that retirement replacement ratio is low and whilst there is lack of awareness of importance of financial planning…
PR Newswire
01/07/2024
uniQure Announces Sale of Commercial Manufacturing Facility to Genezen
~ Proposed divestiture streamlines uniQure's focus and represents an important milestone in its ongoing effort to significantly reduce operating expenses ~ ~ Genezen to manufacture global commercial supply of HEMGENIX ®and support uniQure's pipeline programs as a preferred customer ~ ~ uniQure to reduce cash burn by $40 million per year and receive total consideration of $25 million ~~ uniQure's comprehensive review of operations and options to reduce expenses is ongoing and...
Nasdaq GlobeNewswire
01/07/2024
Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
Mr. Oliveira is an accomplished biopharmaceutical industry executive with nearly 25 years of commercial experience, building high-performing teams, and launching multiple successful pharmaceutical products “As we continue to advance multiple mid- to late-stage clinical development programs, we are thrilled to welcome Orlando to the Zenas leadership team,” said Joe Farmer, President and Chief Operating Officer. “His expertise and track record of building and leading high performing...
Nasdaq GlobeNewswire
01/07/2024
ALLATRA President Discussed Climate Change with Pope Francis
Among the invited guests were Dr. A. Egon Cholakian, a National Security Expert, Washington D.C. Governmental Affairs Advisor to the ALLATRA International Public Movement, CAPP Foundation member; and Maryna Ovtsynova, President of the ALLATRA International Public Movement. Among the invited guests wereDr. A.Egon Cholakian , a National Security Expert,Washington D.C.Governmental Affairs Advisor to the ALLATRA International Public Movement, CAPP Foundation member; and Maryna...
PR Newswire
01/07/2024
Alvotech Announces Record Preliminary Results for Revenues and EBITDA for the…
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced certain preliminary, unaudited key financial information for the second quarter and six months ended June 30, 2024, as follows: Strong preliminary revenue growth with total revenues for the second quarter between $196 - $201 million. Preliminary total revenues for the first six months are $233 - $238 million, an approximately...
Nasdaq GlobeNewswire
01/07/2024
US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems
Press release, Helsinki, 1 July 2024 at 11:30 AM (EEST) US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") announces that it has received an order and delivered two new NBS 6 systems to a private clinic customer in the United States. The customer is an experienced Nexstim system user that is now upgrading its existing systems at two clinic locations.Nexstim launched NBS 6, a new generation nTMS system, in 2023...
Nasdaq GlobeNewswire
01/07/2024
IFPA Celebrates Success of the 7th IFPA Conference 2024
Under the theme "Uncovering the Broad Spectrum of Psoriatic Disease," this year's conference aimed to foster international collaboration on research, advocacy initiatives, and awareness among medical professionals and industry stakeholders. Delegates from over 76 countries convened at the IFPA Conference 2024, representing a diverse array of clinical experts, health professionals, and patient organizations. Accredited by the European Accreditation Council for Continuing Medical...
PR Newswire
01/07/2024
KFSHRC Performs Over 5,000 Successful Kidney Transplants
RIYADH, Saudi Arabia, July01, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully performed 5,000 kidney transplants since the inception of its Transplant Program in 1981, placing it among a select group of leading global health centres that have achieved this milestone. Last year alone, KFSHRC has performed 80 paediatric kidney transplants, the highest number conducted by any hospital in a single year. This achievement makes KFSHRC's...
Nasdaq GlobeNewswire
01/07/2024
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked…
COPENHAGEN, Denmark, July 1, 2024– Bavarian Nordic today announced the conversion of its existing undrawn DKK 1 billion syndicated revolving credit facility (RCF) into a sustainability-linked loan (SLL).The RCF agreement, entered with Danske Bank and Nordea in October 2023, has a three-year tenor with two one-year extension options and provides additional financial flexibility, e.g., to absorb fluctuations in working capital or to fulfil periodic significant milestone payments related to...
Nasdaq GlobeNewswire
01/07/2024
Groupe Casino sells over €200M of real estate assets to Tikehau Capital
Groupe Casino sells over €200M of real estate assets to Tikehau Capital Paris, 1 July 2024Groupe Casino has signed a binding agreement with Tikehau Capital for the sale, in the second half of 2024, of a portfolio of 30 real estate assets comprising hypermarket and supermarket premises leased to the Casino, Intermarché, Carrefour and Auchan banners, as well as ancillary lots within these real estate complexes, some with real estate development potential. The sale price is to be paid in...
Nasdaq GlobeNewswire
01/07/2024
Dawn Health and Merck are collaborating to support Growth Disorders care
By harnessing the latest AI technologies, the collaboration will also involve exploring the integration of features such as growth predictions and advanced personalization into the digital product, with excitement about AI and its potential for impact on user experience, adoption, adherence, and treatment outcomes. The digital solution will provide support to children and young adults living with GHD, as well as providing tools and support to their caregivers, both at home and in a clinical…
PR Newswire
01/07/2024
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US…
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDAMont-Saint-Guibert(Belgium), July 1, 2024 , 8:00am CET / 2:00am ET –(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company submitted the fourth and final module of its Premarket Approval (PMA) application for Genio to the U.S. Food and Drug...
Nasdaq GlobeNewswire
01/07/2024
LIfT BioSciences appoints Antonin (Tony) de Fougerolles as Chairman of its Board…
LIfT BioSciences appoints Antonin (Tony) de Fougerolles as Chairman of its Board of DirectorsLondon,1 July 2024– LIfT BioSciences, ('LIfT' or 'the Company'), a rapidly emerging biotech company preparing to start clinical trials for its first-in-class allogeneic innate cell therapy, today announces the appointment of Antonin (Tony) de Fougerolles, PhD as Chairman of its Board.Tony brings over 25 years of biotech R&D experience in building out drug pipelines and bringing...
Nasdaq GlobeNewswire
01/07/2024
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results…
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab inAcute Lymphoblastic Leukemia in the Journal 'Blood'Nantes, France – July 1 st, 2024 – 7:30 am CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE)today announced the publication of an article on latest preclinical efficacy data on the use of its anti-IL-7 receptor (IL-7RA&io) antagonist Lusvertikimab (OSE-127) for the treatment of B- and T-Cell Acute Lymphoblastic...
Nasdaq GlobeNewswire
01/07/2024
Altri Comunicati
